Axogen
AXGN
Axogen (AXGN) - Total debt
Total debt on the balance sheet as of December 2023 : $69.29 M
According to Axogen's latest financial reports the company's total debt is $69.29 M. A company’s total debt is the sum of all current and non-current debts.
Axogen - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $69.29 M | 2.77% |
| 2022-12-31 | $67.42 M | -0.04% |
| 2021-12-31 | $67.45 M | 25.46% |
| 2020-12-31 | $53.76 M | 1514.05% |
| 2019-12-31 | $3.33 M | 5187.3% |
| 2018-12-31 | $0.06 M | -99.74% |
| 2017-12-31 | $24.54 M | 0.96% |
| 2016-12-31 | $24.31 M | -1.58% |
| 2015-12-31 | $24.7 M | -1.53% |
| 2014-12-31 | $25.08 M | -1.1% |
| 2013-12-31 | $25.36 M | 17.53% |
| 2012-12-31 | $21.58 M | 346.01% |
| 2011-12-31 | $4.83 M | -42.53% |
| 2010-12-31 | $8.41 M | |
| 2004-12-31 | $0 M | -96.63% |
| 2003-12-31 | $0.07 M | -93.56% |
| 2002-12-31 | $1.16 M | 9.51% |
| 2001-12-31 | $1.06 M | |
| 2001-06-30 | $0.89 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | $25.18 B | 36,241.86% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $34.91 B | 50,291.10% | 🇺🇸 USA |
 Boston Scientific BSX | $11.00 B | 15,776.29% | 🇺🇸 USA |